SCHEMBL4410085

SCHEMBL4410085

Cc1ccc(NC(=O)c2cc(N3CCCC3)cc(C(F)(F)F)c2)cc1-c1cc(C(=O)NC2CCOCC2)on1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 5/20 0.57
RAF1 P04049 16/20 0.56
BRAF P15056 16/20 0.56
LYN P07948 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4408515 0.99 CSF1R (0.56) CSF1RRAF1BRAFLYN
SCHEMBL5603601 0.97 CSF1R (0.60) CSF1RRAF1BRAF
SCHEMBL4411100 0.92 RAF1 (0.58) CSF1RRAF1BRAFLYN
SCHEMBL4541529 0.87 RAF1 (0.57) CSF1RRAF1BRAF
SCHEMBL4410928 0.86 RIPK2 (0.48) RAF1BRAF
SCHEMBL5603594 0.86 CSF1R (0.48) CSF1RRAF1BRAF
SCHEMBL4411709 0.86 RIPK2 (0.47) RAF1BRAF
SCHEMBL5593491 0.85 RAF1 (0.60) CSF1RRAF1BRAF
SCHEMBL4417023 0.84 RAF1 (0.56) CSF1RRAF1BRAFLYN
SCHEMBL4412866 0.84 RAF1 (0.56) CSF1RRAF1BRAFLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed